In a special meeting Aug. 11, shareholders of CardioDynamics approved the company’s merger with hand-carried ultrasound pioneer SonoSite.
CardioDynamics set to join SonoSite
In a special meeting Aug. 11, shareholders of CardioDynamics approved the company’s merger with hand-carried ultrasound pioneer SonoSite. Under the $10 million cash deal, they will receive $1.35 per share, representing a 69% premium over the closing share price on June 8, 2009, the day before the definitive merger agreement was announced. The shareholder vote clears the way for CardioDynamics, which makes the BioZ impedance cardiography technology, to join SonoSite as a wholly owned subsidiary. The technology helps diagnose and assess high blood pressure and ventricular function.
Mammography Study Compares False Positives Between AI and Radiologists in DBT Screening
May 8th 2025For DBT breast cancer screening, 47 percent of radiologist-only flagged false positives involved mass presentations whereas 40 percent of AI-only flagged false positive cases involved benign calcifications, according to research presented at the recent American Roentgen Ray Society (ARRS) conference.